Cited by 18DNA Repair MechanismsTelomeres, Telomerase, and SenescenceCancer-related Molecular Pathways

Bin1 Interacts with and Restrains the DNA End-Binding Protein Complex Ku

Open access
Ramalingam, Arivudainambi, Farmer, George E., Stamato, Thomas, Prendergast, George C.·2007·Cell Cycle

Abstract

The Bin1 gene encodes a BAR adapter protein that suppresses cancer by poorly defined mechanisms. In an effort to gain insights, we identified cellular proteins that form biochemical complexes with Bin1 protein. Here we report that Bin1 physically binds to Ku, a DNA end-binding protein that functions in telomere maintenance, apoptosis, and DNA repair. Both Ku70 and Ku80 were purified from human and murine cell extracts using the Bin1 BAR domain as an affinity matrix. A BAR domain mutation that destroys antioncogenic activity completely abolished Ku binding, supporting functional relevance. To further evaluate meaning, we investigated interactions between the Bin1 homolog hob1+ and the Ku homologs pku70+ and pku80+ in fission yeast. Notably, deleting pku70+ or pku80+ relieved the survival defect displayed by hob1delta cells after treatment with the DNA damaging agent phleomycin, suggesting that hob1+ may restrain Ku. Consistent with this notion, telomere length was altered in hob1delta cells. The potential relevance of Bin1-Ku interaction to cancer are discussed in light of these findings.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/cc.6.15.4514

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The BAR domain is known as a binding platform for several protein-protein interactions.

    “However, the BAR domain is also known as a binding platform for several protein-protein interactions (37,38), suggesting that BACE1 is a novel cargo protein of BIN1 that is sorted from early endosomes to late endosomes/lysosomes.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 4

  1. Ge K, DuHadaway J, Sakamuro D, Wechsler-Reya R, Reynolds C, Prendergast GC. Losses of the tumor suppressor Bin1 in breast carcinoma are frequent and reflect deficits in a pro- grammed cell death capacity. Int J Cancer 2000; 85:376-83.
  2. Ge K, Minhas F, DuHadaway J, Mao NC, Wilson D, Sakamuro D, Buccafusca R, Nelson P, Malkowicz SB, Tomaszewski JT, Prendergast GC. Loss of heterozygosity and tumor sup- pressor activity of Bin1 in prostate carcinoma. Int J Cancer 2000; 86:155-61.
  3. Chang M, Boulden J, Sutanto-Ward E, Duhadaway JB, Soler AP, Muller AJ, Prendergast GC. Bin1 mosaic null mice exhibit increased reproductive fecundity and cancer incidence during aging. Cancer Res 2007; In press.
  4. Bahler J, Wu, Jq, Longtime MS, Shah NG, McKenzie A, Steever AB, Wach A, Philippsen P, Pringle JR. Heterologous modules for efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombe. Yeast 1998; 14:943-51.

Cited by

Sorted by citations

Authors
Ramalingam, A., Farmer, G. E., Stamato, T., & Prendergast, G. C.
Affiliations
  • Lankenau Institute for Medical Research (US)
  • DuPont (United States) (US)
  • Thomas Jefferson University (US)
Venue
Cell Cycle
Published
2007-08
Volume
6
Issue
15
Pages
1914-1918
ISSN
  • 1538-4101 (ISSN-L)
  • 1551-4005
OpenAlex
W2051388309
Cited by
18
References
36
Citations by year
2025: 3 · 2023: 1 · 2021: 1 · 2019: 2 · 2016: 1 · 2014: 1 · 2013: 1 · 2012: 1
FWCI
0.53
Type
journal article
Language
en
Open access
Locations
  • Cell Cycle (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R01CA082222, R01CA100123, R01CA109542, CA 82222)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
BIN1, Ku70, Ku80, BAR domain, protein-protein interaction, telomere maintenance, DNA end binding, DNA repair, apoptosis, Schizosaccharomyces pombe, telomere length
MeSH terms
Ku Autoantigen, Animals, Carrier Proteins, Cytoskeletal Proteins, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Binding, Schizosaccharomyces, Signal Transduction, Tumor Suppressor Proteins, Schizosaccharomyces pombe Proteins, Antigens, Nuclear, Cell Line, Tumor, Adaptor Proteins, Signal Transducing, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review